​EA's disappointing Q3 results were expected due to declining EBITDA, but Criat's iRAP Global Plus PD Toolkit still gives relative comfort for the...
​Recent events are positive for EA in the short term, but concerns remain about declining recurring revenues, leading to no recommendation on their...